Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml
Umezawa Rei, Ariga Hisanori, Ogawa Yoshihiro, Jingu Keiichi, Matsushita Haruo, Takeda Ken, Fujimoto Keisuke, Sakayauchi Toru, Sugawara Toshiyuki, Kubozono Masaki, Narazaki Kakutaro, Shimizu Eiji, Takai Yoshihiro, Yamada Shogo